The 2020 Clinical Trial Summit is a half-day program designed specifically for those planning and conducting clinical trials or those who are seeking advice when selecting outsourced providers.

CRISPR pioneer Jennifer Doudna, PhD (University of California, Berkeley/HHMI) was recently awarded the 2020 Nobel Prize in Chemistry with Emmanuelle Charpentier, PhD, a microbiologist at the Max Planck Institute in Berlin. In 2012, the Doudna and Charpentier labs teamed up to publish a landmark paper in which they adapted the CRISPR microbial anti-viral defense system...

As an industry, we produce data. Lots of it. It is inherent to what we do and clearly necessary for bringing innovative therapies to patients. Whether it is monitoring patient data for safety or operational data for oversight purposes, the pandemic has escalated data accessibility to a top strategic priority for companies. Increasingly, Sponsors are...

In celebration of mRNA Day 2020, TriLink is proud to present back-to-back webinars by two pioneers of the mRNA therapeutic platform: Dr. Katalin Kariko and Dr. Drew Weissman. Dr. Kariko will provide an overview of the history of mRNA therapeutics, while Dr. Weissman will provide his perspective on the future of mRNA medicines. In a...

Join four days of digital partnering and establish new global connections thanks to pre-arranged one-on-one ZOOM meetings. Biotechgate Digital Partnering is designed to support the business development of Biotech, Medtech and Pharma companies.

MassBio’s President & CEO, Bob Coughlin, will host a regular virtual Town Hall for members. This will be an opportunity for our members to ask questions, hear what MassBio is up to, and learn more about the state of the industry amidst the COVID-19 pandemic. This Town Hall will feature Matthew Harrison, a Managing Director and...

Join BIO and LaVoieHealthScience for our next Global Market View webinar on December 1 at 10:30AM ET. Our panel of industry leaders with share their perspectives on several topics including private, public, US, EU and China markets, JPM virtual week, the 2020 election, new company formation, year-end regulatory reviews and record financing through NewCo IPO's,...

The prospect of raising capital for early stage companies (pre-seed to Series A) in times of uncertainty always present challenges. Funders continue to invest in companies they have worked with previously, but for the first time entrepreneur or the novice team attracting the right type of capital, the process is longer and more arduous. But...

Important news! After carefully monitoring the global COVID-19 situation over recent months and out of concern for the health and well being of all our attendees, sponsors, and staff, we have decided on a different format for this year’s Scrip Awards. For the first time ever, the Scrip Awards is going digital! We are delighted...

Executive leaders from leading next-generation biotechnology companies will provide exclusive insights into their personal quests for funding the growth of innovation. We will explore where they went right, when they took the wrong turn, what they never expected, and how they would chart a different course for the journey. From the initial concept, to building...

Global Health Authorities have long recognized the need to facilitate development and minimize delays in patient access for novel treatments intended for serious and life-threatening disease. Over the past decade, FDA, EMA and PMDA have launched various “expedited programs” to foster collaboration with industry in the delivery of these promising new therapies. This speaker series will...